100 Most Influential People in Healthcare – 2018

The interim CEO of 340B Health, Testoni has been in the middle of the political storm swirling around the federal program this year. Her group, which advocates for hospitals in the 340B drug pricing program, has pushed for legislation that would not only reverse cuts to the program, but force drug manufacturers to publicly disclose pricing information.